Syndax Pharmaceuticals SNDX Stock Price Movement Behavior Q4 2025 Earnings Underperform PreDiagnosis Dementia Financial Risk and Household LongTerm Wealth Planning Analysis CRBP Corbus posts narrower than expected Q4 2025 loss yet shares dip 157 percent in todays trading